文献速递角膜与眼表疾病

光学失败的治疗性角膜移植后重复移植的长期功能与解剖结局

Long-term Functional and Anatomic Outcomes of Repeat Graft After Optically Failed Therapeutic Keratoplasty.
PubMed 文献 · Am J Ophthalmol · 2018-03-14

前瞻性介入病例系列纳入32眼因治疗性穿透性角膜移植光学失败而行重复光学穿透性角膜移植者,平均随访18.4±8.9个月;1年植片透明率63.14%,末次随访植片存活率降至50%,43.8%视力≥20/200且无眼视力≥20/40,初始治疗植片≥8.75 mm(HR 3.56)及≥1象限深血管化(HR 10.99)与植片存活不良相关,继发性青光眼占59.4%(19/32)。

要点

  • 重复穿透性角膜移植后1年植片透明率63.14%,末次随访存活率降至50%。
  • 43.8%术眼视力≥20/200,无术眼视力≥20/40。
  • 初始治疗植片≥8.75 mm及≥1象限深血管化与植片存活不良相关。

核心结论

  • 治疗性穿透性角膜移植后重复移植与欠佳的视力结局和长期植片存活相关。
  • 初始治疗植片尺寸大和深血管化对植片存活有不良影响。

研究设计与样本

  • 前瞻性介入病例系列,在顶级三级医疗中心为期1年纳入所有因治疗性穿透性角膜移植光学失败而接受重复角膜移植的病例。
  • 所有眼均行重复光学穿透性角膜移植,共32眼,平均随访18.4±8.9个月。
  • 随访时间为第1天、第7天、1、3、6、12个月,此后每年一次。

主要发现

  • 重复移植后1年植片透明率为63.14%,末次随访时植片存活率降至50%。
  • 43.8%的病例视力≥20/200,无病例视力≥20/40。
  • 多变量Cox回归分析显示,初始治疗植片尺寸≥8.75 mm的植片存活风险比(HR)为3.56,1个或以上象限深血管化的HR为10.99。
  • 初始治疗植片尺寸<8.75 mm的病例在植片存活(P = .004)、视力(P = .039)和排斥率(P = .036)方面显著更优。
  • 重复移植后继发性青光眼发生率为59.4%(19/32)。

关键数值与推荐

  • 主要结局指标为术后植片透明度和视力。
  • 次要结局指标为并发症,包括植片排斥、感染、失败和继发性青光眼。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the functional and anatomic outcomes of repeat penetrating keratoplasty (PK) in optically failed therapeutic grafts. DESIGN: Prospective interventional case series. METHODS: All cases admitted at the apex tertiary care center for repeat keratoplasty following optically failed therapeutic PK were enrolled over a period of 1 year. Repeat optical PK was performed in all eyes. Primary outcome measures were postoperative graft clarity and visual acuity. Secondary outcome measures were complications including graft rejection, infections, failure, and secondary glaucoma. Follow-up examinations were undertaken on day 1; on day 7; at 1, 3, 6, and 12 months; and yearly thereafter. RESULTS: Thirty-two eyes underwent repeat PK with mean follow-up of 18.4 ± 8.9 months. Clear grafts were observed in 63.14% of cases 1 year after regraft, and graft survival further decreased to 50% at last follow-up. Visual acuity ≥ 20/200 was achieved in 43.8% of cases, and no case had a visual acuity of ≥ 20/40. Multivariate Cox regression analysis analyzed risk factors for regraft survival, and observed a hazard ratio of 3.56 with size of initial therapeutic graft ≥ 8.75 mm, and 10.99 with deep vascularization in 1 or more quadrants. Graft survival (P = .004), visual acuity (P = .039), and rejection rates (P = .036) were significantly better in cases with initial therapeutic graft size < 8.75 mm. Secondary glaucoma was present in 59.4% (19/32) after regrafts. CONCLUSION: Regraft after therapeutic PK is associated with suboptimal visual outcomes and long-term graft survival. Large size of initial therapeutic graft and deep vascularization adversely affect graft survival.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Srujana D, Kaur M, Urkude J, et al. Long-term Functional and Anatomic Outcomes of Repeat Graft After Optically Failed Therapeutic Keratoplasty. Am J Ophthalmol. 2018. PMID: 29550189. doi:10.1016/j.ajo.2018.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。